IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences | DEF 14A: Definitive information statements
IGM Biosciences | DEFA14A: Others
IGM Biosciences | 8-K: Current report
IGM Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
IGM Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
IGM Biosciences | 8-K: IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: Current report
IGM Biosciences | S-3: Registration statement for specified transactions by certain issuers
IGM Biosciences | 8-K: IGM Biosciences Announces Third Quarter 2023 Financial Results
IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: IGM Biosciences Announces Second Quarter 2023 Financial Results
IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: Current report
No Data
No Data